Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Interviews as Topic × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 2 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Gynecologic 1

Conditions

Interventions

Paclitaxel 23 Carboplatin 23 pembrolizumab 19 Gemcitabine 19 Nivolumab 17 Cisplatin 13 Pemetrexed 11 Bevacizumab 11 Ipilimumab 10 Erlotinib Hydrochloride 10 Docetaxel 10 Capecitabine 10 Fluorouracil 9 eribulin 8 Irinotecan 8 Everolimus 8 BI 6727 8 Albumin-Bound Paclitaxel 8 130-nm albumin-bound paclitaxel 8 Afatinib 7 lenvatinib 6 Trastuzumab 6 Oxaliplatin 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 Cyclophosphamide 6 olaparib 5 avelumab 5 abemaciclib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03599661 2025-01-09

Developing and Validating Fertilit-e

Wake Forest University Health Sciences

21 enrolled 6 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡